GENE - Genetic Technologies Limited
| Previous Close | 1.3400 |
| Open | 1.3400 |
| Bid | 1.3000 x 1000 |
| Ask | 1.4300 x 20100 |
| Day's Range | 1.3001 - 1.3500 |
| 52 Week Range | 0.7000 - 2.0500 |
| Volume | 49,989 |
| Avg. Volume | 124,057 |
| Market Cap | 22.689M |
| Beta | 4.29 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3000 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.50 |
CNW Group•last monthInvictus MD Strategies Corp. Opens the Market
Invictus MD Strategies Corp. Opens the Market
- PR Newswire•last month
Invictus MD Strategies Corp. Opens the Market
TORONTO , March 20, 2018 /CNW/ - Dan Kriznic , Chairman, CEO, Founder & Director, alongside Gene Simmons , Co-Founder of KISS, and Chief Evangelist Officer, Invictus MD Strategies Corp. (GENE), joined ...
- GlobeNewswire•last month
Genetic Technologies Limited Announces Further Collaborative Research with The University of Melbourne to Broaden the Applicability of the BREVAGenplus® Breast Cancer Risk Assessment Test
MELBOURNE, Australia, March 16, 2018-- Genetic Technologies Limited, a diversified molecular diagnostics company embracing blockchain technologies across genomic testing platforms, announced today the ...
- PR Newswire•2 months ago
Shivom Partnership With Genetic Technologies Will Enable Better Cancer Prediction and Prevention Through Mass Genomic Data Analysis
NASDAQ: GENE) to accelerate the prediction of cancer for millions of individuals worldwide. GTG, whose lead product is BREVAGenplus® - a clinically validated risk assessment test for non-hereditary breast cancer - is at the forefront of preventive medicine.
- GlobeNewswire•2 months ago
Genetic Technologies Limited: Project Shivom Strategic Alliance
MELBOURNE, Australia, March 06, 2018-- Genetic Technologies Limited a diversified molecular diagnostics company; provider of BREVAGen plus ®, a first-in-class, clinically validated risk assessment test ...
- GlobeNewswire•2 months ago
Genetic Technologies Announces Strategic Alliance and Capital Raising
MELBOURNE, Australia, Feb. 15, 2018-- Genetic Technologies Limited a molecular diagnostics company and provider of BREVAGen plus ®, a first-in-class, clinically validated risk assessment test for sporadic ...
- GlobeNewswire•2 months ago
Genetic Technologies Limited: Update on Strategic Alliance
MELBOURNE, Australia, Feb. 12, 2018-- Genetic Technologies Limited, wishes to advise that the Company is presently in discussions with the ASX regarding the possible application of ASX Listing Rule 11.1; ...
- GlobeNewswire•2 months ago
Change of Chief Executive Officer
MELBOURNE, Australia, Feb. 06, 2018-- Genetic Technologies Limited, advises that the Board and Mr Eutillio Buccilli have today agreed that Mr Buccilli step down as Chief Executive Officer with immediate ...
- GlobeNewswire•2 months ago
Appointment of Chairman
MELBOURNE, Australia, Feb. 05, 2018-- Genetic Technologies Limited, is pleased to announce that the Board of Directors has appointed Dr Paul A. Kasian as Chairman. This follows previous Chairman Dr Malcolm. ...
- GlobeNewswire•3 months ago
Results from 31 January 2018 General Meeting
MELBOURNE, Australia, Jan. 31, 2018--. Genetic Technologies Limited advises that a General Meeting of shareholders that had been requisitioned pursuant to section 249 D of the Corporations Act was held ...
- GlobeNewswire•3 months ago
Resignation of Directors
MELBOURNE, Australia, Jan. 30, 2018-- Genetic Technologies Limited, advises that Dr Malcolm R. Brandon and Mr Grahame Leonard, AM have resigned as directors of the Company with effect from 29 January, ...
- GlobeNewswire•3 months ago
Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 31 December 2017
Completed a three month promotional campaign leading up to and throughout October Breast Cancer Awareness Month Ohio State University: patient recruitment for the collaborative clinical research study ...
- Benzinga•3 months ago
Benzinga Pro's 5 Stocks To Watch Today
Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! Helios and Matheson Analytics Inc (NASDAQ: HMNY ) ...
- ACCESSWIRE•7 months ago
Today's Research Reports on Stocks to Watch: Tetraphase Pharmaceuticals and Genetic Technologies
NEW YORK, NY / ACCESSWIRE / October 5, 2017 / Shares of Tetraphase Pharma and Genetic Technologies both climbed higher on Wednesday. Despite any news to serve as a catalyst for the gains, shares of Genetic ...
- ACCESSWIRE•8 months ago
Corporate News Blog - Genetic Technologies Announces Comprehensive Review of Strategic Alternatives
Research Desk Line-up: Enzymotec Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 28, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Genetic ...
- Marketwired•8 months ago
Genetic Technologies Announces Comprehensive Review of Strategic Alternatives
Genetic Technologies Limited , a molecular diagnostics company focused on cancer risk assessment, and provider of BREVAGenplus®, a first-in-class, clinically validated risk assessment test for non-hereditary ...
- Marketwired•9 months ago
Genetic Technologies Launches Breast Cancer Awareness Month Promotion for BREVAGenplus(R)
Genetic Technologies Limited , a molecular diagnostics company specialising in cancer genomics, and provider of BREVAGenplus®, a first-in-class, clinically validated risk assessment test for non-hereditary ...
- Marketwired•9 months ago
Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 30 June 2017
Genetic Technologies Limited
- Marketwired•9 months ago
Genetic Technologies Receives Nasdaq Deficiency Notice
Genetic Technologies Limited , today announced that on 20 July 2017, it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market, notifying the Company that ...